Axillary lymph node dissection (ALND) is the gold standard for evaluating axillary lymph node metastasis (ALNM), but ALND may not confer a survival advantage. Therefore, reliable, noninvasive approaches for preoperative prediction of ALNM have been needed. The use of machine learning (ML) in predicting ALNM in breast cancer patients has been reported. We have conducted a large-sample-size assessment and a meta-analysis of published studies concerning the diagnostic performance of ML-based MRI in predicting ALNM in breast cancer patients.
This abstract and the presentation materials are available to members only; a login is required.